Glycopyrrolate Injection
Product Images NDC 0143-9587

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0143-9587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glycopyrrolate Injection Novaplus 1)

FDA Label Image

Glycopyrrolate Injection Novaplus 10

This text provides product identification information including GTIN (Global Trade Item Number), SN (Serial Number), expiration date (EXP), and LOT number. However, without additional context, it is not possible to determine the specific product associated with this information.*

FDA Label Image

Ndc 0143-9587-01 Rx Only Glycopyrrolate Injection, Usp 1 mL Single Dose Vial 0.2 mg/ml Contains Benzyl Alcohol For Im Or Iv Use (Glycopyrrolate Injection Novaplus 2)

This is a description of Glycopyrrolate Injection, USP. It contains 0.2 mg/mL and is for IM or IV use only. The injection is distributed by Hikma and contains Benzyl Alcohol. The product is packaged under the brand name NovaPlus and the National Drug Code (NDC) is 0143-9587-01. The lot number and expiration date are also provided.*

FDA Label Image

Ndc 0143-9587-25 Rx Only Glycopyrrolate Injection, Usp 25 X 1 mL Single Dose Vials 0.2 mg/ml Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration Water For Injection, Usp Q.s./benzyl Alcohol, Nf (preservative) 0.9%. Ph Adjusted, When Necessary, With Hydrochloric Acid And/or Sodium Hydroxide. Usual Dosage: See Package Insert. Store At 20° To 25°c (68° To 77°f) [see Usp Controlled Room Temperature]. (Glycopyrrolate Injection Novaplus 3)

This is a description of the medication Glycopyrrolate Injection, USP. It comes in single dose vials with a volume of 251mL and dosage of 0.2mg/m. It should not be used on newborns and contains Benzyl Alcohol. The medication is meant for IM or IV use and consists of Water for Injection and Benzyl Alcohol with an adjusted pH using hydrochloric acid and/or sodium hydroxide. The usual dosage is indicated on the package and it should be stored at temperatures between 20-25°C. The product is manufactured by IO ARAAGELTEA PORTUGL 54, and labeled as novaplus™+.*

FDA Label Image

Ndc 0143-9586-01 Rx Only Glycopyrrolate Injection, Usp 2 mL Single Dose Vial 0.4 mg/2 mL (0.2 mg/ml) Contains Benzyl Alcohol For Im Or Iv Use (Glycopyrrolate Injection Novaplus 4)

This is a description of a medication called Glycopyrrolate. It is only available with a prescription (Rx ONLY) and is administered via injection (IM or IV). The medication comes in a 2 mL single dose vial containing 0.4 mg per 2 mL (0.2 mg/mL) and contains Benzyl Alcohol. The manufacturer is Hikma and it is distributed under the name "novaplus". The lot and expiration information are unavailable.*

FDA Label Image

Ndc 0143-9586-25 Rx Only Glycopyrrolate Injection, Usp 25 X 2 mL Single Dose Vials 0.4 mg/2 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration Water For Injection, Usp Q.s./benzyl Alcohol, Nf (preservative) 0.9%. Ph Adjusted, When Necessary, With Hydrochloric Acid And/or Sodium Hydroxide. Usual Dosage: See Package Insert. Store At 20° To 25°c (68° To 77°f) [see Usp Controlled Room Temperature]. (Glycopyrrolate Injection Novaplus 5)

This is a description of Glycopyrrolate injection, which comes in a package of 25 single-dose 2 mL vials, with each vial containing 0.4 mg of the solution. The injection contains Benzyl Alcohol and is for Intramuscular or Intravenous use only and is not suitable for newborns. The usual dosage of the injection is mentioned on the package insert. It should be stored at 20°C to 25°C, and it is imported and distributed by a company called NovaPlus.*

FDA Label Image

Ndc 0143-9585-01 Rx Only Glycopyrrolate Injection, Usp 5 mL Multiple Dose Vial 1 mg/5 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration Water For Injection, Usp Q.s./ Benzyl Alcohol, Nf (preserva- Tive) 0.9%. Ph Adjusted, When Necessary, With Hydrochloric Acid And/or Sodium Hydroxide. Usual Dosage: See Package Insert. Store At 20° To 25°c (68° To 77°f). (Glycopyrrolate Injection Novaplus 6)

This appears to be a label for a medication called Glycopyrrolate Injection, with a concentration of 0.2 mg/mL, and packaged in a single-dose vial under the brand name novaplus®. The label also includes a lot number and expiration date.*

FDA Label Image

Ndc 0143-9585-25 Rx Only Glycopyrrolate Injection, Usp 25 X 5 mL Multiple Dose Vials 1 mg/5 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration Water For Injection, Usp Q.s./benzyl Alcohol, Nf (preservative) 0.9%. Ph Adjusted, When Necessary, With Hydrochloric Acid And/or Sodium Hydroxide. Usual Dosage: See Package Insert. Store At 20° To 25°c (68° To 77°f) [see Usp Controlled Room Temperature]. (Glycopyrrolate Injection Novaplus 7)

Glycopyrrolate is a prescription injection available in 25 x 5 mL vials with a strength of 1mg per 5 mL. It is not recommended for newborns and contains Benzyl Alcohol. The injection is for intramuscular or intravenous use and should be stored between 20°C to 25°C. The pH is adjusted as necessary with hydrochloric acid and/or sodium hydroxide. The usual dosage is provided in the package insert. The product is manufactured and distributed by KA FARVACEUTIGA in Portugal and the NDC (National Drug Code) is 0143-9585-25.*

FDA Label Image

Ndc 0143-9584-01 Rx Only Glycopyrrolate Injection, Usp 20 mL Multiple Dose Vial 4 mg/20 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration Water For Injection, Usp Q.s./benzyl Alcohol, Nf (preservative) 0.9%. Ph Adjusted, When Necessary, With Hydrochloric Acid And/or Sodium Hydroxide. Usual Dosage: See Package Insert. Store At 20° To 25°c (68° To 77°f) [see Usp Controlled Room Temperature]. (Glycopyrrolate Injection Novaplus 8)

Glycopyrrolate Injection is a medication used for intramuscular or intravenous administration. It is available in a 20 mL multiple dose vial and contains 4 mg per 20 mL. However, it is not recommended for use in newborns and contains benzyl alcohol. The solution is a mixture of water for injection and benzoic acid. The pH and ionic strength can be adjusted if necessary using citric acid and/or sodium hydroxide. It is recommended to check the dosage instructions on the package insert. The medication should be stored at a temperature of 20–25°C (68–77°F).*

FDA Label Image

Ndc 0143-9584-10 Rx Only Glycopyrrolate Injection, Usp 10 X 20 mL Multiple Dose Vials 4 mg/20 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration Water For Injection, Usp Q.s./benzyl Alcohol, Nf (preservative) 0.9%. Ph Adjusted, When Necessary, With Hydrochloric Acid And/or Sodium Hydroxide. Usual Dosage: See Package Insert. Store At 20° To 25°c (68° To 77°f) [see Usp Controlled Room Temperature]. (Glycopyrrolate Injection Novaplus 9)

This text provides information about a medication called Glycopyrrolate. The medication is available in injections and comes in a pack of 10 x 20 mL Multiple Dose vials, with each vial containing 4 mg per 20 mL (0.2 mg/m). It is not for use in newborns and contains Benzyl Alcohol. The medication can be administered intramuscularly or intravenously. The packaging has instructions on how to open it, and it contains Water for injection and Benzyl Alcohol as a preservative. The medication should be stored at 20° to 25°C (68° o 77°F) [See USP Controlled Room Temperature].*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.